Fierce Pharma

MARCH 25, 2024

Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S. | Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S. officials are pressing the company to pay royalties linked to the commercialization of its lucrative Pfizer-partnered COVID-19 vaccine.

353

353

MedCity News

MARCH 25, 2024

AbbVie is acquiring Landos Biopharma, whose lead drug is a small molecule that takes a novel approach to treating ulcerative colitis. Preliminary proof-of-concept data from a Phase 2 study are expected later this year.

Biopharma 118

Biopharma Leads Pharma 118

Fierce Pharma

MARCH 25, 2024

In 2023, Eli Lilly CEO David Ricks received a 24% boost in pay from $21.4 million to $26.6 million. The increase coincides with the company's booming sales.

Sales 358

Sales 358

pharmaphorum

MARCH 25, 2024

Novo Nordisk has agreed to buy Cardior Pharmaceuticals for $1.1 billion, adding expertise in RNA therapeutics and a heart failure therapy in mid-stage trials.

Pharmaceutical 118

Pharmaceutical 118

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MARCH 25, 2024

With the FDA expected this week to approve a first-in-class treatment from Merck for pulmonary arterial hypertension (PAH), Johnson & Johnson has beaten its New Jersey rival to the punch with a | With the FDA expected this week to approve a first-in-class treatment from Merck for pulmonary arterial hypertension (PAH), Johnson & Johnson has beaten its New Jersey rival to the punch with a nod from the U.S. regulator for its newest PAH treatment.

FDA 307

FDA 307

PharmaVoice

MARCH 25, 2024

As the new weight loss drugs take the world by storm, companies in other areas are battening the hatches for when slimmer patients need fewer medical interventions.

Medical 111

Medical Patients 111

MedCity News

MARCH 25, 2024

It’s a complex, multifaceted problem that no magic bullet will solve — but more visibility into the data behind hiring and salaries for RNs may help. Here’s a look at how.

109

109

Fierce Pharma

MARCH 25, 2024

Nearly five years after an FDA approval for Soliris in neuromyelitis optica spectrum disorder (NMOSD), AstraZeneca’s follow-on C5 drug Ultomiris has entered the rare neurological disease, as well.< | Nearly five years after an FDA approval for Soliris in neuromyelitis optica spectrum disorder (NMOSD), AstraZeneca’s follow-on C5 drug Ultomiris has entered the rare neurological disease, as well.

FDA 267

FDA 267

MedCity News

MARCH 25, 2024

Novo Nordisk’s strategy to grow beyond metabolic diseases includes expanding into adjacent areas such as cardiovascular disease. Acquiring Cardio Pharmaceuticals adds a novel RNA-based therapy that is a potential heart failure treatment.

Pharmaceutical 113

Pharmaceutical Biopharma Pharma 113

Fierce Pharma

MARCH 25, 2024

When it comes to questioning drug patents, the U.S. Federal Trade Commission (FTC) isn’t backing down. | After filing a challenge in November against more than 100 patents in the FDA’s Orange Book—and persuading several drugmakers to retract their intellectual property (IP) protections in the process—the U.S. Federal Trade Commission is now calling out uncooperative companies in court.

263

263

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

MARCH 25, 2024

FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat two common forms of non-Hodgkin lymphoma

FDA 107

FDA Marketing 107

MedCity News

MARCH 25, 2024

David Kereiakes, managing partner with Windham Venture Partners, shared his perspective of the health tech sector and investment trends he’s seeing.

Healthcare 113

Healthcare Healthcare Management 113

European Pharmaceutical Review

MARCH 25, 2024

Astellas Ireland, a wholly owned subsidiary of Astellas, has officially marked the start of construction of a new €330 million manufacturing facility at Kerry Technology Park in Tralee, Ireland. The ground-breaking ceremony, held on 25 March, was attended by Irish government officials as well as project partners and senior executives from Astellas. The new 17,000 square meter state-of-the-art facility will accelerate the expansion of Astellas’ in-house manufacturing capabilities, including for a

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Engineering Government 98

MedCity News

MARCH 25, 2024

During an interview this month at HIMSS24, David Vawdrey — Geisinger’s chief data and informatics officer said health systems should spend more time designing their plan for evaluating success when it comes to tech pilots.

Healthcare 107

Healthcare Healthcare 107

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

MARCH 25, 2024

Three digital health technologies (DHTs) used to support patients with psychosis can be used by the NHS while additional evidence of their benefits is gathered.

Patients 105

Patients 105

MedCity News

MARCH 25, 2024

Data strategy requires understanding all data feeds and ensuring secure, privacy-compliant data access and governance. How you use your data is the primary concern. The systems and tools are secondary.

Healthcare 100

Healthcare Healthcare Government 100

Pharmaceutical Technology

MARCH 25, 2024

The US FDA approved Johnson & Johnson's (J&J) OPSYNVI for chronic treatment in adult patients with pulmonary arterial hypertension.

FDA 98

FDA Patients 98

MedCity News

MARCH 25, 2024

Many women going through menopause suffer brain fog, but some may be worried about a more serious cognitive condition like dementia. Because of this, Midi Health and Neurotrack partnered to offer a cognitive assessment to patients.

Patients 99

Patients 99

Advertisement

pharmaphorum

MARCH 25, 2024

The March meeting of the EMA’s human medicines committee saw an approval recommendation for Novartis’ Fabhalta, on track to become the first oral monotherapy for rare disease paroxysmal nocturnal haemoglobinuria (PNH) in the EU.

Medicine 90

Medicine 90

Pharmaceutical Technology

MARCH 25, 2024

Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) grant for developing the lung cancer vaccine LungVax.

98

98

PharmaVoice

MARCH 25, 2024

Deborah Reardon is leading a new pillar that asks, ‘Are we looking at this from a patient lens and not from a Boehringer lens?

Patients 98

Patients Leads 98

Pharmaceutical Technology

MARCH 25, 2024

The FDA granted accelerated approval for the drug back in November 2022, and granted priority review in December 2023.

FDA 98

FDA 98

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmExec

MARCH 25, 2024

Action marks the first FDA approval of a long-acting treatment for adult patients with neuromyelitis optica spectrum disorder who are positive for the anti-aquaporin-4 antibody.

FDA 52

FDA Patients 52

Pharmaceutical Technology

MARCH 25, 2024

The CRISPR-based assay significantly accelerates the current diagnostic process, which can last for months and could revolutionise the way NTM infections are diagnosed.

59

59

PharmaTech

MARCH 25, 2024

In this episode of the Drug Solutions Podcast, Jan Bekkar, director of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Marketing 52

Marketing 52

Spotio

MARCH 25, 2024

Want to succeed in the solar industry? You need to optimize your company’s solar sales funnel. If you don’t, you won’t be able to attract qualified prospects, close deals, and drive revenue. Of course, wanting to improve your solar sales process and actually doing it are different things. To help, we’ve put together this comprehensive guide, which will help you understand the unique aspects of selling solar products, the four distinct stages of the solar sales funnel, bes

Sales 52

Sales Prospecting Sales process Sales pitches 52

Advertisement

Distribution

Impetus Digital

MARCH 25, 2024

This is a guest article and does not necessarily reflect the views and values of Impetus Digital. Data breaches can happen in any industry, and unfortunately, pharmaceutical companies aren’t immune to this threat. With a handful of big names responsible for dispensing billions of prescriptions across the US each year, Pharma companies are the keepers of vast amounts of data and, as such, are attractive targets for cybercriminals.

Management 52

Management Pharma Education Training 52

Penrod

MARCH 25, 2024

The ideal healthcare ecosystem is one where the patient thrives and the hospital functions at peak efficiency. However, this is only sometimes a reality, as miscommunication, wasted resources, and missed opportunities plague operations. Disparate systems often cause inefficiencies – hospitals cannot harness the power of their data because that data is not unified.

Healthcare 52

Healthcare Healthcare CRM Customer Relationship Management 52

Pharmaceutical Commerce

MARCH 25, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, Adrianna Nava, PhD, MPA, MSN, RN, President, National Association of Hispanic Nurses (NAHN) talks about the organization's mission and goals.

Pharma 52

Pharma 52

Penrod

MARCH 25, 2024

In this article, I’ll interpret the updated guidance and describe what has changed – and what hasn’t. The updated guidance covers three main points: Defining tracking technologies The differences between tracking on authenticated pages, unauthenticated pages, and mobile apps Your obligations under HIPAA What are tracking technologies? The updated guidance starts by redefining tracking technology – and this is smart because I get tons of questions from healthcare providers about wheth

Healthcare Provider 52

Healthcare Provider Healthcare Healthcare Marketing 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales